Skip to content

Study of Effect of Food Containing Resistant Maltodextrin on Postprandial Serum Triglyceride

Study of Effect of Food Containing Resistant Maltodextrin on Postprandial Serum Triglyceride - Effect of Food Containing Resistant Maltodextrin on Postprandial Serum Triglyceride

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014115
Enrollment
90
Registered
2014-05-30
Start date
2014-05-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No (subjects with high postprandial serum triglyceride)

Interventions

Food containing resistant maltodextrin, 1 food Food not containing resistant maltodextrin, 1 food

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)(Healthy) subjects aged 20 to 64 years old. (2)Subjects whose fasting serum triglyceride levels are from 120 mg/dL to 200 mg/dL. (3)Subjects giving written informed consent.

Exclusion criteria

Exclusion criteria: (1)Subjects who use oral medication affecting lipid metabolism. (2)Subjects who constantly use supplements and/or functional foods affecting lipid metabolism. (3)Subjects with excessive alcohol-drinking behaviors. (4)Subjects who can't stop drinking for 2 days until the screening checkup (5)Subjects who declare the allergy symptoms against high-fat diets. (6)Subjects who have a history of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder. (7)Subjects who have a chronic disease and use medicines continuously. (8)Subjects who have a history of digestive disease affecting digestion and absorption. (9)Subjects who are judged as unsuitable for the study based on the results of blood test. (10)Subjects who have donated over 200 mL of blood and/or blood component within the last one month prior to the current study or over 400 mL of blood and/or blood component within the last three months prior to the current study. (11)Subjects who is diagnosed as familial hyperlipidemia. (12)Subjects who is diagnosed as severe anemia and not suitable for frequent collection of blood. (13)Subjects who have under treatment or a history of drug addiction and/or alcoholism. (14)Subjects who are planned to participate in other clinical study. (15)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. (16)Subjects who are judged as unsuitable for the study by the investigator for other reason.

Design outcomes

Primary

MeasureTime frame
Postprandial Serum Triglyceride

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Corporation Sales department

yoshikawa@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026